mail2

Spectrum Library

Antibodies to myelin oligodendrocyte glycoprotein in aquaporin 4 antibody seronegative longitudinally extensive transverse myelitis: Clinical and p… – PubMed – NCBI

Mult Scler. 2015 Jul 24. pii: 1352458515591071. [Epub ahead of print]

Source: Antibodies to myelin oligodendrocyte glycoprotein in aquaporin 4 antibody seronegative longitudinally extensive transverse myelitis: Clinical and p… – PubMed – NCBI

Antibodies to myelin oligodendrocyte glycoprotein in aquaporin 4 antibody seronegative longitudinally extensive transverse myelitis: Clinical and prognostic implications.

Author information

  • 1Multiple Sclerosis Unit, Hospital Universitari de Bellvitge, Spain acobo@bellvitgehospital.cat.
  • 2Center of Neuroimmunology, Service of Neurology, Hospital Clínic and Institut d’Investigació Biomèdica August Pi i Sunyer (IDIBAPS), Universitat de Barcelona, Barcelona, Spain.
  • 3Neurology Department, CHU Toulouse, France/Center for Pathophysiology of Toulouse Purpan, INSERM U1028/CNRS 5282, France.
  • 4Lyon Neuroscience Research Center, INSERM U1028/CNRS 5292, France.
  • 5Multiple Sclerosis Unit, Hospital Universitari de Bellvitge, Spain.
  • 6Lyon Neuroscience Research Center, INSERM U1028/CNRS 5292, France/Service de Neurologie A, Hôpital Neurologique Pierre Wertheimer, France.

Abstract

OBJECTIVE:

We aimed to investigate the frequency and clinical significance of antibodies to myelin oligodendrocyte glycoprotein (MOG-abs) in patients who presented with a first episode of seronegative aquaporin 4 antibody (AQP4-ab) longitudinally extensive transverse myelitis (LETM).

METHODS:

Epidemiological, clinical, and paraclinical data of 56 patients from three European centres were analysed. Patients were retrospectively tested for MOG-abs and AQP4-abs, by cell-based assays.

FINDINGS:

Thirteen (23.2%) patients were MOG-ab positive. Among the 56 patients, six (10.7%) converted to neuromyelitis optica (NMO), one (1.8%) to multiple sclerosis (MS), nine (16.1%) had recurrent LETM, and 40 (71.4%) remained as monophasic LETM. Compared with seronegative patients, those with MOG-abs were younger (median: 32.5 vs 44 years; p=0.007), had cerebrospinal fluid pleocytosis more frequently (94% vs 45%, p=0.003) and had better outcome (median Expanded Disability Status Scale (EDSS) 2.0 vs 3.0, p=0.027). MOG-ab positive patients also showed an increase risk of optic neuritis relapse and NMO conversion (p=0.010).

CONCLUSION:

Patients with MOG-abs in AQP4-ab seronegative LETM have clinical distinctive features, higher risk of optic neuritis relapses, and better outcome than patients seronegative.

© The Author(s), 2015.

KEYWORDS:

Longitudinally extensive transverse myelitis; aquaporin-4 antibody; multiple sclerosis; myelin oligodendrocyte glycoprotein; neuromyelitis optica

PMID:
26209592
[PubMed – as supplied by publisher]